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Abstract. One of the primary outcomes of a software process assessment is 
visibility of the capability of a software process which among other things, 
informs us of the ability of a process to deliver consistent product quality levels. 
In safety critical domains, such as the medical device sector, high product 
quality – and particularly high product safety - is an important consideration. 
To address this safety concern, the medical device sector traditionally employs 
audits to determine compliance to software process standards and guidance. 
Unlike an audit which results in a pass/fail outcome, an assessment provides a 
process capability profile which identifies areas for improvement and enables a 
comparison with broader best practice. MDevSPICE® integrates the various 
medical device software standards and guidance within the infrastructure of a 
SPICE assessment model, thus encompassing aspects of compliance and 
capability. This paper describes some of the key enablers of this integration. 
Keywords: Safety Critical Software ∙ Medical Device Software ∙ Software 
Process Improvement ∙ Software Process Assessment ∙ MDevSPICE®. 
1     Introduction 
Safety critical software is software which if not operating correctly can result in 
harm or even death to humans [1]. It is therefore the case that safety critical software 
development should take additional steps beyond general software development to 
specifically address safety considerations. Medical device software is of a safety 
critical nature and regulators have implemented legal requirements (or regulations) 
which must be met prior to placing a device on the market. Whereas general software 
development studies have demonstrated that software developers may be unwilling to 
embrace a strong software process focus [2], such processes are a mandatory 
requirement in the medical device sector. These regulations are typically regional in 
application, with the Food and Drug Administration (FDA) and the European 
Commission (EC) regulating for the US and EU respectively.  
In the case of the EU, medical device regulation is contained in the Medical Device 
Directive (MDD) 93/42/EEC [3], the Active Implantable Medical Device Directive 
(AIMDD) 90/385/EEC [4], and the In-vitro Diagnostic (IVD) Medical Device 
Directive 98/79/EC [5] – with MDD 2007/47/EC [6] amending these earlier 
directives. In the US, the FDA advances medical device regulation through Code of 
Federal Regulation (CFR) Title 21, Chapter I, Subchapter H, Part 820 [7]. In both the 
EU and the US regulations, provisions are made for classifying medical devices 
depending on the role of the device, ranging from Class I to Class III depending on 
the extent of the role of the device in supporting or sustaining human life. Various 
standards and guidance exists to support manufacturers developing medical devices in 
adhering to the regulations, and compliance to these standards will generally enable 
market access. Primary among these standards are ISO 14971 [8], ISO 13485 [9], IEC 
TR 80002-1 [10], IEC 62304:2006 [11], IEC TR 80002-3 [12], IEC 62366 [13], IEC 
60601-1 [14], IEC 82304 [15]), the FDA guidance documents on premarket 
submission [16], off-the-shelf software use [17] and software validation [18]. These 
standards and guidance documents are presented in Figure 1 and in further detail in 
[19]. 
Despite the existence of regulation, standards and guidance for medical device 
software, the proportion of medical devices being recalled owing to software errors is 
growing. From a base of less than 10% for most of the 1990s, the proportion of 
medical device recalls attributable to software errors hit 24% in 2011 [20] and this 
trend would appear to be set to continue upwards. Although one of the reasons for this 
growth is undoubtedly the increasing use of software in medical devices, other factors 
such as inadequacies in the software development process could have a role to play. 
To help address this undesirably upward trend in the proportion of medical device 
recalls attributable to software errors, the introduction of a SPICE-based process 
assessment may be of benefit, especially given the significant positive impact that 
SPICE models have had within other safety critical sectors, e.g. Automotive SPICE 
[21]. 
2     Integrating Medical Device Standards into SPICE 
While there are potentially significant benefits to be derived from the use of SPICE 
based assessment in the medical device sector, the task of integrating the existing 
medical device standards and guidance into the SPICE framework is a challenging 
one. Medical device standards and guidance are rich in detail, varied in origin, and 
sometimes with overlapping content. As a result, a significant burden of effort is 
required to integrate these disparate sources into a single, comprehensive framework. 
Furthermore, SPICE frameworks do not typically trace the origin of different process 
requirements – rather, a SPICE assessment is performed against the accumulated best 
practice that is incorporated into the framework. Therefore, the following significant 
challenge emerged during the development of MDevSPICE®: 
 
Challenge: How can the origin of different process requirements 
be carried forward into a SPICE framework such that 
assessments can also assist manufacturers in addressing their 
basic standards compliance requirements? 
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2.1      Process Lineage 
To address the challenge identified above, we determined to identify the source for 
various specific standards and guidance contained within the MDevSPICE® Process 
Assessment Model (PAM). All MDevSPICE® assessments operate upon the basic 
assumption that IEC 62304 is within the scope of an assessment – as it is the globally 
recognised standard that should be adopted when performing medical device software 
development. Therefore, IEC 62304 requirements form the foundation of 
MDevSPICE® [22]. In fact, an important foundation to this was the publication of 
IEC 80002-3 [12] by the developers of MDevSPICE® as a Process Reference model 
for IEC 62304. IEC 80002-3 was then used as the starting point for the development 
of the MDevSPICE® PAM. Software safety classification (detailed in IEC 62304) is a 
concept similar to medical device classification, with three classes existing and these 
being determined based upon the worst possible consequence in the case of a software 
failure.  
 Building on IEC 62304, additional details incorporated from aligned standards and 
guidance documents retain information regarding the source of such details. For 
example, in the case of the Software Architectural Design process, when describing 
the software architecture (which is the first base practice for this process), there is an 
explicit reference to an item of FDA Guidance on the use of off the shelf software, 
specifically addressing the treatment of Software Of Unknown Provenance (SOUP) as 
follows: 
 
FDA on OTS: identify the expected design limitations of the SOUP Software. 
 
There are many further examples of such additions and indications in the 
MDevSPICE® PAM, for instance, in the Software Requirements Analysis process, 
there is an addition to base practice five Verify Software Requirements, as follows: 
 
FDA on Validation: A software requirements traceability analysis should be 
conducted to trace software requirements to (and from) risk analysis results. 
 
While software process adaptation is considered advantageous in a general sense 
[23], it is however a requirement for medical device manufacturers since regulation 
(and corresponding standards and guidance) is subject to change. In this respect, 
MDevSPICE® is of particular benefit to manufactures. Through our work in the 
Regulated Software Research Centre, the creators of MDevSPICE® will continue to 
work with the international standards organisations to develop and improve standards 
and guidance, with corresponding updates being further applied to the MDevSPICE® 
framework. Thus, manufacturers can continually adopt MDevSPICE® for the purpose 
of staying abreast of standards and guidance evolution. 
   
2.2      Assessment Questions  
To further aid MDevSPICE® Assessors, a suite of detailed questions has been 
developed as a counterpart to the PAM. The detailed questions are directly linked to 
the PAM, with specific questions designed to address aspects of the PAM that have 
been incorporated from sources other than IEC 62304 and which therefore could be 
important within the context of determining approximate standard or guidance 
compliance. It should be noted that it is not the intention to use MDevSPICE® 
assessments to certify compliance to individual standards. Instead, MDevSPICE® is 
used to determine the capability of the software development process relative to the 
accumulated best practice information available. Having process lineage to individual 
source standards and guidance, and providing a set of corresponding questions does 
however permit a reasonably accurate approximation to standards compliance and it is 
possible that in the fullness of time and subject to robust validation, MDevSPICE® 
could concurrently address the capability consideration that is central to all SPICE 
assessments (and which enables targeted process improvement and supplier selection) 
in tandem with undertaking a compliance audit (which would enable market access).      
3     Conclusion 
Safety critical software development is often subject to regulation, with that 
regulation being realized through the implementation of associated standards and 
guidance. The aim of regulations is to reduce the risk of harm to humans in so far as is 
possible. This is achieved through the adoption of a robust software development 
process – with such a process effectively increasing product quality and thereby 
safety. Process assessment frameworks such as SPICE have been designed to achieve 
(among other things) higher levels of product quality and have been used to good 
effect in safety critical domains such as the automotive sector. Therefore, 
MDevSPICE® was developed for the medical device sector to deliver a view on 
process robustness though the capability lens, while simultaneously providing an 
approximation to standards and guidance compliance. However, standards 
compliance and process capability are not necessarily natural bedfellows, and the 
creation of MDevSPICE® has had to incorporate some innovations to enable the 
integration of both concerns. Specifically in this respect, MDevSPICE® retains 
linkage to the source standards. To further enable the harmonization of compliance 
and capability considerations, the MDevSPICE® PAM has an associated set of 
questions that align with the process components in the PAM. Through the 
MDevSPICE® process question set, MDevSPICE® Assessors can consistently 
examine both process capability and standards alignment in a single engagement, and 
this, we believe, represents an important step forward for medical device software 
development.  
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